Legal Opinion
In Re Cyclobenzaprine Hydrochloride
District Court, D. Delaware
Decided May 12, 2011No. Civ. 09-2118-SLRPublishedCited by 5 opinions
1Opinion of the Court
OPINION
SUE L. ROBINSON, District Judge.
I. INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”) 1 by Mylan Pharmaceuticals, Inc. (“Mylan”), Barr Laboratories, Inc. (“Barr”), Impax Laboratories, Inc. (“Impax”) and Anchen Pharmaceuticals, Inc. (“Anchen”) to market a generic version of the pain drug AMRIX® proprietary to Eurand, Inc. (“Eurand”) and exclusive licensee Anesta AG (“Anesta”) (collectively “plaintiffs”). The active ingredient in AMRIX® is cyclobenzaprine hydrochloride (“cyclobenzaprine”) in an extended release formulation, which is protected…
2Cases cited57 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Edward H. Phillips v. Awh Corporation, Hopeman Brothers, Inc., and Lofton Corporation, Defendants-CrossCourt of Appeals for the Federal Circuit · 2006
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- Vitronics Corporation v. Conceptronic, Inc.Court of Appeals for the Federal Circuit · 1996
52 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Wm. Wrigley Jr. Co. v. Cadbury Adams USA LLCCourt of Appeals for the Federal Circuit · 2012
- ALLERGAN, INC. v. Sandoz, Inc.District Court, E.D. Texas · 2011
- Intercontinental Great Brands v. Kellogg North America CompanyCourt of Appeals for the Federal Circuit · 2017
- Intercontinental Great Brands v. Kellogg North America CompanyCourt of Appeals for the Federal Circuit · 2017
- Wm. Wrigley Jr. Co. v. Cadbury Adams USA LLCCourt of Appeals for the Federal Circuit · 2012